Comprehensive Introduction to Ictal and Interictal SPECT

For patients living with drug-resistant epilepsy, identifying the precise origin of seizures—the "epileptogenic zone"—is the most critical step toward surgical intervention. When standard imaging like MRI fails to show a clear structural lesion, functional imaging becomes the gold standard. Ictal and Interictal SPECT (Single-Photon Emission Computed Tomography) is a highly specialized nuclear medicine procedure that maps cerebral blood flow to localize where a seizure begins.

Unlike static imaging, SPECT captures the dynamic changes in the brain's metabolism and blood perfusion. By comparing a scan taken during a seizure (ictal) to one taken while the patient is seizure-free (interictal), clinicians can pinpoint hyper-perfused areas that indicate the seizure focus. This guide serves as an authoritative resource for patients, caregivers, and medical professionals regarding the technical, clinical, and procedural aspects of this diagnostic tool.

Technical Specifications and Mechanisms of Action

SPECT imaging relies on the principle of "neurovascular coupling." When neurons become hyperactive during a seizure, they require more oxygen and glucose, leading to a local increase in regional cerebral blood flow (rCBF).

The Radiopharmaceutical

The procedure utilizes a radiotracer, typically Technetium-99m HMPAO (hexamethylpropylene amine oxime) or ECD (ethyl cysteinate dimer). These tracers are lipophilic, meaning they cross the blood-brain barrier easily. Once inside the brain, they are "trapped" in proportion to the blood flow at the exact moment of injection.

The Physics of the Scan

1. Injection: The tracer is injected intravenously. Because the tracer reflects blood flow at the moment of injection, the timing is paramount.
2. Distribution: The tracer distributes within seconds and remains fixed in the brain tissue for several hours.
3. Detection: A gamma camera rotates around the patient's head, detecting the gamma rays emitted by the tracer.
4. Reconstruction: Computer algorithms reconstruct these 2D projections into a 3D map of brain perfusion.

Clinical Indications and Usage

Ictal and Interictal SPECT are primarily indicated for patients with medically refractory focal epilepsy who are candidates for epilepsy surgery.

Primary Indications

• MRI-Negative Epilepsy: Used when structural MRI scans are normal, but clinical evidence suggests focal seizures.
• Surgical Planning: Defining the resection margins for neurosurgeons.
• Multifocal Suspicions: Helping distinguish between multiple potential seizure foci.
• Post-Operative Assessment: Evaluating why seizures may persist after initial surgery.

The SISCOM Technique

Clinicians often use a process called SISCOM (Subtraction Ictal SPECT Coregistered to MRI). This involves:
1. Acquiring the Ictal SPECT.
2. Acquiring the Interictal SPECT.
3. Subtracting the Interictal from the Ictal.
4. Coregistering the resulting "difference map" onto the patient’s high-resolution MRI.
This creates a visual "hot spot" that highlights the exact area of increased perfusion, providing a clear roadmap for the surgical team.

Patient Preparation and Procedure Steps

Preparation for a SPECT scan is intensive, as it requires the patient to be monitored in an epilepsy monitoring unit (EMU) until a seizure occurs.

Step-by-Step Procedure

1. Admission: The patient is admitted to the EMU. Antiepileptic medications are often tapered to provoke a seizure.
2. Monitoring: Continuous video-EEG monitoring is applied to detect the onset of a seizure.
3. The Injection: As soon as the seizure begins, the nurse or technician injects the radiotracer. Speed is critical; the tracer must be injected within 20–30 seconds of seizure onset to ensure the image reflects the ictal state.
4. Post-Ictal Period: After the seizure, the patient is stabilized.
5. The Scan: The patient is transported to the nuclear medicine department. The scan can be performed several hours after injection because the tracer is fixed in the brain.
6. Interictal Scan: On a separate day, the patient is scanned while seizure-free to provide the baseline data.

Risks, Side Effects, and Contraindications

While SPECT is a valuable diagnostic tool, it involves exposure to ionizing radiation and the necessity of inducing seizures.

Risks

• Radiation Exposure: The procedure uses a small amount of radioactive material. The dose is comparable to other nuclear medicine studies, but should be avoided in pregnant women unless absolutely necessary.
• Seizure Induction: Because the patient is often tapered off medication to induce a seizure, there is a risk of status epilepticus or injury during the seizure event.
• Allergic Reactions: Rare, but potential for reaction to the radiopharmaceutical.

Contraindications

• Pregnancy: Generally contraindicated unless the benefit outweighs the risk.
• Unstable Medical Status: Patients who cannot tolerate a seizure or the medication withdrawal process.
• Inability to Remain Still: Patients with severe movement disorders may require sedation, which can interfere with EEG patterns.

Interpretation of Results

The interpretation of SPECT scans requires a multidisciplinary team, including a neurologist (epileptologist) and a nuclear medicine radiologist.

• Normal Result: Perfusion is symmetrical across both hemispheres. No focal areas of hyper-perfusion are identified.
• Abnormal Result (Ictal): A clear, focal area of increased uptake (hyper-perfusion) is seen in the region where the seizure originated.
• Abnormal Result (Interictal): Often shows hypoperfusion (decreased uptake) in the same area as the ictal hyper-perfusion, reflecting the underlying tissue dysfunction.

Frequently Asked Questions (FAQ)

1. Is SPECT the same as an MRI?

No. An MRI looks at the structure of the brain, while SPECT looks at the function and blood flow. They are often used together for better accuracy.

2. How long does the radioactive tracer stay in my body?

The tracer used (Technetium-99m) has a short half-life of about 6 hours. It is excreted through the kidneys and is usually cleared from the body within 24–48 hours.

3. Does the injection hurt?

The injection is a standard intravenous line insertion, similar to a blood draw. The radiotracer itself does not cause pain.

4. Why do I need to be off my seizure medications?

Medications suppress seizure activity. To capture a seizure during the SPECT scan, we often need to reduce or stop them in a controlled hospital setting to ensure the seizure occurs while the equipment is ready.

5. Can I eat before the scan?

Generally, yes. However, check with your specific epilepsy center, as some protocols may require fasting depending on the specific facility guidelines.

6. What if I don't have a seizure during my hospital stay?

This is a known risk. If a seizure does not occur, the ictal scan cannot be performed. The team will discuss alternative diagnostic options, such as PET scans or invasive EEG monitoring.

7. How accurate is SPECT in localizing seizures?

When combined with MRI (SISCOM), SPECT has a high sensitivity for localizing the epileptogenic zone, often exceeding 80-90% in experienced centers.

8. Will the scan make me feel different?

Most patients do not feel any different after the injection. The primary stressor is the seizure itself, not the imaging procedure.

9. Can children undergo this procedure?

Yes, SPECT is used in pediatric epilepsy centers. The dose of the radiotracer is adjusted based on the child's weight.

10. How long does the actual scanning process take?

The actual time inside the SPECT camera is typically 30 to 60 minutes. You must remain very still during this time to ensure clear images.

Conclusion

Ictal and Interictal SPECT remain cornerstone technologies in the evaluation of complex epilepsy. By bridging the gap between clinical observation and anatomical imaging, these scans provide the precision required to offer hope for seizure freedom through surgery. If you or a loved one are considering this procedure, ensure it is performed at a Level 4 Epilepsy Center where specialized expertise in both neurology and nuclear medicine is available.